Seegene, Institutional Investors Net Buy 215,192 Shares in Last 5 Days... Stock Price 268,500 KRW (+6.04%)

As of 1:30 PM on the 16th, Seegene is trading at 268,500 KRW, up 6.04% from the previous day. The trading volume is 2,439,754 shares, which is 248.81% of the previous day's volume. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

On September 16, Hana Financial Investment researchers Sun Min-jung and Kang Seung-won stated, "With third-quarter sales increasing compared to the second quarter, Seegene's sales this year are estimated to exceed 1 trillion KRW. Due to the high transmissibility of the COVID-19 virus, which can cause outbreaks as soon as quarantine measures are relaxed, the pandemic is expected to become a long-term battle. In 2021, Seegene's sales are also estimated to increase by more than 7%, maintaining sales around 1.1 trillion KRW. Given the long-term nature of the COVID-19 pandemic and earnings growth in the third and fourth quarters, there is a need to re-rate the valuation." They set Seegene's target price at 350,000 KRW.

Over the past five days, individual investors have net sold 108,971 shares of Seegene, while foreigners and institutions have net sold 100,669 shares and net bought 215,192 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.